Table 1 Demographic characteristics of methadone patients, United States 2020 (N = 392)
Region* | |
West | 8.2% (32) |
South | 42.1% (165) |
Midwest | 21.2% (83) |
Northeast | 26% (102) |
Declined to state | 2.6% (10) |
Gender Identity | |
Male | 18.4% (72) |
Female | 76.0% (298) |
Trans, nonbinary, genderqueer, other | 5.4% (21) |
Declined to state | 0.3% (1) |
Race/Ethnicity | |
White | 85.9% (336) |
Black | 2.0% (8) |
Hispanic | 4.6% (18) |
Native American/Inuit | 3.3% (13) |
Asian/Asian American | 1.5% (6) |
Declined to state | 2.6% (10) |
Age | |
 < 30 | 19.2% (75) |
30–39 | 48.8% (191) |
40–49 | 22.5% (88) |
50 +  | 9.5% (37) |
Declined to state | 0.3% (1) |
Time in Methadone Treatment | |
 <  = 1 year | 9.7% (38) |
1–4 years | 36.7% (144) |
5–10 years | 25.8% (101) |
10 + years | 23.7% (93) |
Declined to state | 4.1% (16) |
Travel Time | |
 < 20 min | 48% (188) |
20–45 min | 30.9% (121) |
45 + minutes | 18.9% (74) |
Declined to state | 2.3% (9) |
Transportation Type | |
Alone (driving, walking, biking) | 66.5% (260) |
Group (Carpool, public transport) | 29.4% (115) |
Declined to state | 4.1% (16) |
Monthly Methadone Cost | |
$0-$19 | 62.8% (246) |
$20–99 | 3.3% (13) |
$100–199 | 6.9% (27) |
$200 +  | 24.2% (95) |
Declined to state | 2.8% (11) |
Health Insurance Type | |
Government-funded | 58.9% (231) |
No Insurance | 13.0% (51) |
Private (company health care plan, Obama care) | 26.8% (105) |
Declined to state | 1.3% (5) |